These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 20637610)
1. Synthesis of novel oxime-containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells. Zheng LW; Li Y; Ge D; Zhao BX; Liu YR; Lv HS; Ding J; Miao JY Bioorg Med Chem Lett; 2010 Aug; 20(16):4766-70. PubMed ID: 20637610 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells. Ding XL; Zhang HY; Qi L; Zhao BX; Lian S; Lv HS; Miao JY Bioorg Med Chem Lett; 2009 Sep; 19(18):5325-8. PubMed ID: 19683442 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary biological evaluation of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives as potential agents against A549 lung cancer cells. Zhang JH; Fan CD; Zhao BX; Shin DS; Dong WL; Xie YS; Miao JY Bioorg Med Chem; 2008 Dec; 16(24):10165-71. PubMed ID: 19013820 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and discovery of autophagy inducers for A549 and H460 lung cancer cells, novel 1-(2'-hydroxy-3'-aroxypropyl)-3-aryl-1H-pyrazole-5-carbohydrazide derivatives. Fan CD; Zhao BX; Wei F; Zhang GH; Dong WL; Miao JY Bioorg Med Chem Lett; 2008 Jul; 18(14):3860-4. PubMed ID: 18595694 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Zheng LW; Wu LL; Zhao BX; Dong WL; Miao JY Bioorg Med Chem; 2009 Mar; 17(5):1957-62. PubMed ID: 19217789 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of pyrazole peptidomimetics and their inhibition against A549 lung cancer cells. Liu YR; Luo JZ; Duan PP; Shao J; Zhao BX; Miao JY Bioorg Med Chem Lett; 2012 Nov; 22(22):6882-7. PubMed ID: 23044370 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of 5-benzyl-2-phenylpyrazolo[1,5-a]pyrazin-4,6(5H,7H)-dione derivatives and discovery of an apoptosis inducer for H322 lung cancer cells. Lv HS; Kong XQ; Ming QQ; Jin X; Miao JY; Zhao BX Bioorg Med Chem Lett; 2012 Jan; 22(2):844-9. PubMed ID: 22209459 [TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis, crystal structure of pyrazolo[1,5-a]pyrazin-4(5H)-ones and their selective effects on lung cancer cells. Liu N; Zhang JH; Zhao BX; Zhao J; Su L; Dong WL; Zhang SL; Miao JY Eur J Med Chem; 2011 Jun; 46(6):2359-67. PubMed ID: 21463913 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells. Lian S; Su H; Zhao BX; Liu WY; Zheng LW; Miao JY Bioorg Med Chem; 2009 Oct; 17(20):7085-92. PubMed ID: 19773174 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives and their inhibition against growth of A549 and H322 lung cancer cells. Zheng LW; Shao JH; Zhao BX; Miao JY Bioorg Med Chem Lett; 2011 Jul; 21(13):3909-13. PubMed ID: 21640587 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells. Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives. Zhang D; Wang G; Zhao G; Xu W; Huo L Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells. Liu WY; Li HY; Zhao BX; Shin DS; Lian S; Miao JY Carbohydr Res; 2009 Jul; 344(11):1270-5. PubMed ID: 19527904 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287 [TBL] [Abstract][Full Text] [Related]
19. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]